Assenagon Asset Management S.A.
Position in TGTX — Tg Therapeutics, Inc.
CIK 1546007
SENNINGERBERG, N4
Position in TGTX
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$5,036,954
-$11,907,039 QoQ
Shares Held
91,681
-82.0% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#7
of 116 holders
Holding Since
Mar 2021
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $1,943,463,989 across 69 Biotechnology names. TGTX ranks #34 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759,564 | $377,298,225 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
8,362,952 | $295,964,871 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
244,927 | $152,721,781 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
454,682 | $111,292,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,762,086 | $100,826,560 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
997,643 | $78,085,517 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
124,214 | $66,696,707 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
947,495 | $59,635,335 |
All Filings in TGTX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,036,954 | 91,681 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $16,943,993 | 510,054 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $4,781,225 | 160,390 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $420,242 | 11,633 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $222,130 | 6,172 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $243,361 | 6,172 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $3,102,708 | 103,080 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $3,981,773 | 170,234 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $8,698,295 | 488,943 | Shares | Sole | 2024-07-18 | |
| 2023-09-30 | $1,219,272 | 145,846 | Shares | Sole | 2023-11-06 | |
| 2023-03-31 | $3,468,254 | 230,602 | Shares | Sole | 2023-04-18 | |
| 2022-06-30 | $8,878,046 | 2,088,952 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $2,415,806 | 254,028 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $3,071,901 | 161,679 | Shares | Sole | 2022-02-01 | |
| 2021-06-30 | $5,928,004 | 152,823 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $7,531,105 | 156,247 | Shares | Sole | 2021-04-26 | |
| No filing history on record for this holder in this stock. | ||||||